Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

HealthMetrix Research Selects 2017 Medicare Advantage Plans for Exceptional Benefit Value & Overall Performance

Medicare Advantage
Posted on: 18 Oct 16

COLUMBUS, Ohio, Oct. 17, 2016 /PRNewswire/ -- Medicare Advantage plans in over 100 cities will be recognized for exceptional value in the design of their medical and Part D prescription drug benefits available effective January 1.  The 2017 Senior Choice Gold Award recipients were selected from Medicare Advantage plans across 47 states and Puerto Rico based on cost-sharing analysis conducted by HealthMetrix Research Inc. and  The 2017 Senior Choice Gold Award selections include special recognition for plans achieving at least 4-star overall ratings for quality and performance as reported by the Centers for Medicare & Medicaid Services (CMS). 

According to HealthMetrix Research Inc. president Alan Mittermaier:

"This established industry award is unique for considering both forward-looking cost-sharing comparisons along with the recently announced quality and performance ratings.  Each award recipient has demonstrated a commitment to excellence in the design of their 2017 Medicare plan benefits, copayments, deductibles and premiums including the Part D prescription drug benefits.  Over 50% of the award recipients also achieved at least 4-star CMS overall ratings for exceptional performance that creates a higher bar for all Medicare Advantage competitors.  HealthMetrix Research commends those organizations for this distinctive dual recognition."           

The award criteria were based on 2017 benefits and cost-sharing approved by Medicare for the selected plans.  Estimated annual out-of-pocket costs published on Medicare Plan Finder ( include applicable plan copayments, deductibles and premiums adjusted for beneficiaries' health status (Excellent, Good, Poor).  The HealthMetrix Research cost-sharing analysis is available at  HealthMetrix Research neither recommends nor endorses specific Medicare plans.

For more information:

Editor's Details

Mike Wood

Last updated on: 18/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.